Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ermisch

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|April 26, 2011
Protein kinase A activates and phosphorylates RORα4 in vitro and takes part in RORα activation by CaMK-IVMichael Ermisch, Beate Firla, Dieter Steinhilber
Biological Chemistry|November 5, 2011
Dimerization of human 5-lipoxygenaseAnn-Kathrin Häfner, Mihaela Cernescu, Bettina Hofmann, et al.
Journal of Market Access & Health Policy|February 24, 2025
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access AcademyElaine Julian, Tom Belleman, Maria João Garcia, et al.
Applied Health Economics and Health Policy|November 8, 2019
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of OlaratumabCaridad Pontes, Corinne Zara, Josep Torrent-Farnell, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|April 26, 2011
Protein kinase A activates and phosphorylates RORα4 in vitro and takes part in RORα activation by CaMK-IVMichael Ermisch, Beate Firla, Dieter Steinhilber
Biological Chemistry|November 5, 2011
Dimerization of human 5-lipoxygenaseAnn-Kathrin Häfner, Mihaela Cernescu, Bettina Hofmann, et al.
Journal of Market Access & Health Policy|February 24, 2025
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access AcademyElaine Julian, Tom Belleman, Maria João Garcia, et al.
Applied Health Economics and Health Policy|November 8, 2019
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of OlaratumabCaridad Pontes, Corinne Zara, Josep Torrent-Farnell, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Pageof 1